Lifeboat Foundation

Sept 30 (Reuters) — Major social media stars including Kim Kardashian, Justin Bieber and Charli D’Amelio are among celebrities whose Instagram followers experience more negative feelings about their self-image, according to internal Facebook (FB.O) research revealed by the Wall Street Journal this week, raising questions about the impact of celebrity culture online.

The Journal released the leaked research slide decks on Wednesday, which served as the basis of articles it published earlier this month saying that Facebook knew its apps harmed the mental health of some teenage girls and young users.

The research, titled “Social comparison on Instagram,” surveyed 100,000 people in March and April 2020 in nine countries, including the United States, Australia and Brazil.

Summary: The brain’s reward system plays a key role in helping behaviors and empathy.

Source: Tel Aviv University.

Are mammals at all able to demonstrate empathy for one another, engage in pro-social behavior, and help others in distress? New research from the Tel Aviv University examined the issue based on an animal model (rats) and found that just as with humans, rats are also split into various groups with different indicators, to the point that they only come to the aid of members of their group but do not help rats from other groups.

Artificial sweeteners are widely promoted as safe, zero-calorie alternatives to sugar, ideal for those trying to lose weight. But a new study is indicating artificial sweeteners may increase appetite and food cravings, particularly in females and the obese.

“There is controversy surrounding the use of artificial sweeteners because a lot of people are using them for weight loss,” says corresponding author on the new study, Kathleen Page. “While some studies suggest they may be helpful, others show they may be contributing to weight gain, type 2 diabetes and other metabolic disorders. Our study looked at different population groups to tease out some of the reasons behind those conflicting results.”

Page hypothesizes the discordancy in the science is somewhat due to the fact that many studies investigating the effects of artificial sweeteners on metabolic activity or the brain are conducted in mostly male subjects, often with normal weight. This new research set out to investigate the influence of artificial sweeteners on these processes across a broad cohort of men and women.

Genetic diseases are a compelling target for viral gene therapy. One condition that scientists are investigating to see if they can treat with gene therapy is a rare genetic disease called Leber congenital amaurosis, or LCA is a progressive condition that disables critical cells within the retina. The damage begins at birth: it eventually robs patients of central vision and color perception, often rendering them legally blind. But there may be another way. On Wednesday, researchers presented evidence from a breakthrough gene-editing experiment that restored some color vision to patients with LCA vision loss.

CRISPR is already under investigation as a gene therapy for blood disorders like sickle cell disease and beta-thalassemia. It may well have other uses, such as treating cancer by editing mutated DNA. But the process is not without its hurdles. Treatments for blood disorders like these involve taking cells from the patient’s body, changing them in vitro in the lab, and then re-infusing them back into the patient’s body. That works great for blood, which you can take out, filter, and put back in with relatively few consequences.

But because LCA is a disease of the retina, you can’t just take out cells and then infuse them back in. The retina is a delicate, multilayered membrane that resents any disturbance. The eye also has a system of physical defenses not unlike the blood-brain barrier. Furthermore, the immune system sometimes responds with extreme prejudice to eye injuries or infections, to the point of causing an actual autoimmune disease where the body attacks its own eyes. How, then, could researchers get the CRISPR treatment into the retina, past the body’s ferocious defenses and without further damage?

At the SAS 2021 security conference today, analysts from security firm Kaspersky Lab have published details about a new Chinese cyber-espionage group that has been targeting high-profile entities across South East Asia since at least July 2020.

Named GhostEmperor, Kaspersky said the group uses highly sophisticated tools and is often focused on gaining and keeping long-term access to its victims through the use of a powerful rootkit that can even work on the latest versions of Windows 10 operating systems.

“We observed that the underlying actor managed to remain under the radar for months,” Kaspersky researchers explained today.

(https://www.linkedin.com/in/evelyne-yehudit-bischof/) is an expert in internal medicine and oncology, with a focus on preventative and precision medicine, bio-gerontology, and geronto-oncology.

Dr. Bischof is deeply passionate about next-generation medical technology, and the applications of artificial intelligence for biomedical research and practice.

Continue reading “Dr. Evelyne Bischof, MD — Advancing The Frontiers Of Preventative And Precision Longevity Medicine” »

Using far more advanced imaging techniques than those of their earlier contemporaries, researchers at the DOE’s Argonne National Laboratory are working to develop a brain connectome — an accurate map that lays out every connection between every neuron and the precise location of the associated dendrites, axons, and synapses that help form the communications or signaling pathways of a brain.

Sept. 24 2021 — As part of the Aurora Early Science Program, Nicola Ferrier of Argonne National Laboratory is leading a project that will use exascale computing power to help advance efforts to develop a brain connectome.

Continuous operational data is crucial for AI-powered automation—from implementation to routine use. But how do you overcome the existing data gap? https://bit.ly/3kXcNEi

As AI becomes more common, consistent continuous data is a necessity for smarter operations. See how automated sensing drives reliability and efficiency.

With global corporate-venture-capital-backed (CVC) funding reaching $79 billion across 2,099 deals in the first half of 2,021 according to CB Insights, the chances are high that startups will find great opportunities with this growing investor set.

Entrepreneurs, however, are likely to discover that the investment process can be different for CVCs compared to private venture capital firms. While both types of investment firms tend to make decisions via an investment committee (IC), private VCs (inclusive of VCs with corporate backers that have an independent LPA structure) make up their ICs with firm partners and/or other venture-minded people.

But for CVCs investing off a corporate balance sheet, the IC can include corporate-minded people, such as the CEO or business unit leaders, who generally tend to be detached from the venture mindset and the requirements for operating in the VC world. As such, entrepreneurs will realize that a successful CVC investment decision tends to have different requirements compared to a private VC firm’s decision.